Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.
UAB researchers probe basic molecular mechanisms that lead to the lung scarring of pulmonary fibrosis, a lethal disorder.
A key role for microRNA-155 in brain inflammation and neurodegeneration makes it both a potential therapeutic target and a biomarker for this progressive disorder.
Measure of Mpl gene expression reveals a heterogonous population of leukemia stem cells: one group leukemic and the other group non-leukemic.
One major goal is the discovery of new genotype/phenotype correlations — how a particular mutation indicates that some symptoms in patients are unlikely to develop with age.
UAB researchers find that epigenetic changes associated with chronic obesity alter expression of memory-related genes in the brain.
Recognition of a new pathway may change the treatment of allergic diseases.
Kearney was cited for outstanding contributions to B cell biology.
UAB-led research shows how methylating an RNA binding protein leads to alternative RNA splicing. Mutant enzymes are often found in blood cancers.
UAB Research Administration carefully invests to keep investigators competitive in an era of tight grant funding.
The number of U.S. biomedical postdoctoral fellows has fallen for three years in a row, an unprecedented decline that UAB's Louis Justement, Ph.D., and colleagues at the Federation of American Societies for Experimental Biology and Brown University call “an end to the era of expansion.”